|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00618865 |
|
Date of registration:
|
08/02/2008 |
|
Primary sponsor: |
|
|
Public title:
|
Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy
|
|
Scientific title:
|
Omega-3 Polyunsaturated Fatty Acids in Women With Major Depressive Disorders During Pregnancy |
|
Date of first enrolment:
|
June 2004 |
|
Target sample size:
|
36 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00618865 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Eligible participants were pregnant women, aged 18 to 40 years, with major depressive
disorder onset between their 16th week (second trimester) and 32nd week (third
trimester) of gestation at the Department of Obstetrics.
Exclusion Criteria:
- Subjects were excluded with a DSM-IV diagnosis of bipolar disorders, psychotic
disorders, substance abuse or dependence for at least 3 months, or any Axis-II
diagnosis of borderline or antisocial personality disorder.
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Depressive Disorder
|
|
Intervention(s)
|
|
Dietary Supplement: Omega-3 fatty acids
|
|
Secondary ID(s)
|
|
NSC 93-2320-B-039-001
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|